CA Patent

CA2114537A1 — Transdermal therapeutic systems

Assigned to Individual · Expires 1993-02-18 · 33y expired

What this patent protects

Described are transdermal therapuetic systems characterized in that they contain, in an adhesive matrix containing an active substance, a polar penetration enhancer and a non-polar penetration enhancer which is insoluble in the polar penetration enhancer.

USPTO Abstract

Described are transdermal therapuetic systems characterized in that they contain, in an adhesive matrix containing an active substance, a polar penetration enhancer and a non-polar penetration enhancer which is insoluble in the polar penetration enhancer.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2114537A1
Jurisdiction: CA
Classification: —
Expires: 1993-02-18
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.